C17 Globotriaosylceramide (d18:1/17:0) structure
|
Common Name | C17 Globotriaosylceramide (d18:1/17:0) | ||
|---|---|---|---|---|
| CAS Number | 536745-81-0 | Molecular Weight | 1038.349 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 1127.2±65.0 °C at 760 mmHg | |
| Molecular Formula | C53H99NO18 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 635.5±34.3 °C | |
Use of C17 Globotriaosylceramide (d18:1/17:0)C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS. |
| Name | C17 Globotriaosylceramide (d18:1/17:0) |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 1127.2±65.0 °C at 760 mmHg |
| Molecular Formula | C53H99NO18 |
| Molecular Weight | 1038.349 |
| Flash Point | 635.5±34.3 °C |
| Exact Mass | 1037.686157 |
| LogP | 9.62 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.558 |
| N-[(2S,3R,4E)-1-{[α-D-Galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->;4)-β-D-glucopyranosyl]oxy}-3-hydroxy-4-octadecen-2-yl]heptadecanamide |
| C17 Globotriaosylceramide (d18:1/17:0) |
| Heptadecanamide, N-[(1S,2R,3E)-1-[[[O-α-D-galactopyranosyl-(1->4)-O-β-D-galactopyranosyl-(1->4)-β-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]- |